Dr Howard Liu

Radiation Oncologist
Become a Patient

Dr Howard Liu is committed to providing quality, evidence based, patient-focused care. He aims to provide personalised care to meet each individual’s needs and believes it is a privilege to work with patients during what can be their most challenging times.


Dr Howard Liu is a radiation oncologist who practices at Icon Cancer Centre Greenslopes and Princess Alexandra Hospital. He obtained his Bachelor of Medicine, Bachelor of Surgery in Queensland in 2010 before undertaking specialist training in radiation oncology at various tertiary hospitals throughout Queensland. In 2017, Dr Liu started a clinical research fellowship in head and neck cancer and stereotactic radiation therapy at the Princess Alexandra Hospital before his appointment in 2018 as a radiation oncology staff specialist.

Dr Liu is actively involved in clinical and translational research in these fields. He is also involved with medical education of junior doctors and medical students from the University of Queensland. His clinical experience covers a broad range of solid tumour malignancies with a special interest in head and neck oncology, skin cancers, soft tissue sarcoma and stereotactic radiation therapy.

Affiliations & Memberships

  • Australia and New Zealand Sarcoma Association (ANZSA)
  • Australian and New Zealand Head & Neck Cancer Society (ANZHNCS)
  • Royal Australian and New Zealand College of Radiologists (RANZCR)
  • Trans Tasman Radiation Oncology Group (TROG)
  • Faculty of Medicine, University of Queensland

Special Interests

Dr Howard Liu accepts referrals for all cancer types, with a special clinical interest in:
  • Head and neck cancer
  • Sarcoma
  • Skin cancer
  • Stereotactic radiation therapy

Icon Locations

Greenslopes View centre
Auchenflower View centre

Visiting Locations

  • Princess Alexandra Hospital


  • Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma – Initial Experience From an Australian Liver Cancer Service. H. Liu, Y. Lee, K. McLean, D. Leggett, P. Hodgkinson, J. Fawcett, R. Mott, K. Stuart & D. Pryor. Clinical Oncology (The Royal College of Radiologists), 2020; 32(10):e194-202.

  • Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy. H.Liu, R. Milne, G. Lock, B.J. Panizza, A. Bernard, M. Foote, M. McGrath, E. Brown, M. Gandhi, S.V. Porceddu. Oral Oncology, 2019; 88: 153-159.

  • The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer. C.P. Daniels. H. Liu, A. Bernard, C. Williams, M. Foote, R. Ladwa, M. McGrath, B. Panizza & S. Porceddu. Radiotherapy and Oncology, 2002; 151: 242-248.

  • Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium. M.D. Shanker, H. Liu, D. Lee, K.A. Stuart, E.E. Powell, A. Wigg & D. Pryor. Journal of Gastroenterology and Hepatology, 2020.